Literature DB >> 17512274

Peritoneal cytology in colorectal cancer: incidence and prognostic value.

Ugur Gozalan1, Ahmet Cinar Yasti, Yunus Nadi Yuksek, Erhan Reis, Nuri Aydin Kama.   

Abstract

BACKGROUND: The value of peritoneal washing cytology on prognosis is not clear yet. The aims of our prospective study were to consider the incidence and prognostic value of peritoneal cytology.
METHODS: From 1996 to 2003, washing cytology was performed in 88 patients who underwent surgery for colorectal cancer. Before exploration and manipulation of the tumor, each of the peritoneal cavities next to the tumor site, subhepatic and rectovesical recesses, were irrigated with 50 mL saline, and then the aspirates were taken for cytological evaluation.
RESULTS: Thirteen (14.7%) of 88 patients had positive cytology. Although necrosis, depth of invasion, differentiation of the tumor, macroscopic peritoneal dissemination, and ascites were correlated with positive cytology; multivariate analyses revealed the depth of invasion, presence of necrosis, and differentiation of the tumor as the factors affecting the cytology. The disease-free and overall-survival times in patients with positive and negative peritoneal washing cytology were 56.36, 61.40 and 52.08, 63.94 months, respectively (P > .05).
CONCLUSION: The presence of free malignant cells in the peritoneal cavities of patients who underwent curative resection for colorectal cancer provides no further prognostic value over the current staging systems.

Entities:  

Mesh:

Year:  2007        PMID: 17512274     DOI: 10.1016/j.amjsurg.2006.10.020

Source DB:  PubMed          Journal:  Am J Surg        ISSN: 0002-9610            Impact factor:   2.565


  8 in total

1.  Prognostic significance of peritoneal lavage cytology in patients with colorectal cancer.

Authors:  Hirotoshi Kobayashi; Kenjiro Kotake; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2012-02-28       Impact factor: 3.402

Review 2.  Intra-operative peritoneal lavage for colorectal cancer.

Authors:  Guillaume Passot; Kayvan Mohkam; Eddy Cotte; Olivier Glehen
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

3.  Detection methods and clinical significance of free peritoneal tumor cells found during colorectal cancer surgery.

Authors:  Simone Sibio; Cristina Fiorani; Carmine Stolfi; Andrea Divizia; Roberto Pezzuto; Fabrizio Montagnese; Giulia Bagaglini; Paolo Sammartino; Giuseppe Sigismondo Sica
Journal:  World J Gastrointest Surg       Date:  2015-09-27

Review 4.  Incidence and prognostic significance of positive peritoneal lavage in colorectal cancer.

Authors:  Takeshi Nishikawa; Eiji Sunami; Toshiaki Tanaka; Junichiro Tanaka; Tomomitsu Kiyomatsu; Kazushige Kawai; Keisuke Hata; Shinsuke Kazama; Hiroaki Nozawa; Soichiro Ishihara; Toshiaki Watanabe
Journal:  Surg Today       Date:  2014-11-07       Impact factor: 2.549

5.  Lack of prognostic role of pre- and postoperative peritoneal cytology and cytokeratin PCR-expression on local recurrence after curative anterior resection for mid-low rectal cancer.

Authors:  Donato F Altomare; Michele Tedeschi; Maria-Teresa Rotelli; Domenica Bocale; Domenico Piscitelli; Marcella Rinaldi
Journal:  Updates Surg       Date:  2011-04-20

Review 6.  Prognostic significance of isolated tumor cells in patients with colorectal cancer in recent 10-year studies.

Authors:  Yoshito Akagi; Tetsushi Kinugasa; Yosuke Adachi; Kazuo Shirouzu
Journal:  Mol Clin Oncol       Date:  2013-05-09

7.  Factors Affecting Positive Peritoneal Lavage Cytology in Patients with Stage II and III Colorectal Cancer with R0 Resection: A Multi-institutional, Prospective Study.

Authors:  Harunobu Sato; Kenjiro Kotake; Kotaro Maeda; Hirotoshi Kobayashi; Hiroshi Takahashi; Kenichi Sugihara
Journal:  J Anus Rectum Colon       Date:  2021-10-28

8.  Colorectal cancer at high risk of peritoneal metastases: long term outcomes of a pilot study on adjuvant laparoscopic HIPEC and future perspectives.

Authors:  Charlotte E L Klaver; Roos Stam; Didi A M Sloothaak; Johannes Crezee; Willem A Bemelman; Cornelis J A Punt; Pieter J Tanis
Journal:  Oncotarget       Date:  2017-04-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.